Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 65 | 2024 | 8747 | 3.120 |
Why?
|
| Amyloid beta-Peptides | 45 | 2024 | 3909 | 3.060 |
Why?
|
| tau Proteins | 24 | 2024 | 2142 | 2.340 |
Why?
|
| Positron-Emission Tomography | 53 | 2024 | 6670 | 1.990 |
Why?
|
| Memory Disorders | 13 | 2024 | 1203 | 1.860 |
Why?
|
| Neuropsychological Tests | 38 | 2024 | 7145 | 1.450 |
Why?
|
| Diagnostic Self Evaluation | 6 | 2020 | 227 | 1.270 |
Why?
|
| Aniline Compounds | 22 | 2024 | 1094 | 1.130 |
Why?
|
| Cognition Disorders | 11 | 2017 | 3985 | 1.100 |
Why?
|
| Cognition | 21 | 2024 | 7074 | 1.090 |
Why?
|
| Amyloid | 10 | 2024 | 854 | 1.090 |
Why?
|
| Memory | 13 | 2023 | 2210 | 1.010 |
Why?
|
| Tauopathies | 4 | 2020 | 328 | 0.810 |
Why?
|
| Aging | 18 | 2024 | 8764 | 0.780 |
Why?
|
| Apathy | 6 | 2024 | 107 | 0.780 |
Why?
|
| Activities of Daily Living | 12 | 2024 | 2433 | 0.670 |
Why?
|
| Self Report | 8 | 2024 | 3766 | 0.660 |
Why?
|
| Association Learning | 4 | 2015 | 223 | 0.640 |
Why?
|
| Thiazoles | 19 | 2024 | 1542 | 0.620 |
Why?
|
| Aged, 80 and over | 62 | 2024 | 59683 | 0.610 |
Why?
|
| Brain | 24 | 2024 | 27452 | 0.580 |
Why?
|
| Temporal Lobe | 9 | 2024 | 1728 | 0.560 |
Why?
|
| Longitudinal Studies | 29 | 2024 | 14783 | 0.530 |
Why?
|
| Disease Progression | 24 | 2023 | 13646 | 0.530 |
Why?
|
| Aged | 84 | 2024 | 171544 | 0.500 |
Why?
|
| Ethylene Glycols | 5 | 2024 | 198 | 0.490 |
Why?
|
| Entorhinal Cortex | 5 | 2023 | 288 | 0.440 |
Why?
|
| Carbolines | 6 | 2024 | 296 | 0.390 |
Why?
|
| Hippocampus | 10 | 2020 | 3784 | 0.360 |
Why?
|
| Cross-Sectional Studies | 23 | 2024 | 26373 | 0.350 |
Why?
|
| Apolipoprotein E4 | 7 | 2020 | 711 | 0.330 |
Why?
|
| Socioeconomic Factors | 3 | 2020 | 7861 | 0.320 |
Why?
|
| Male | 82 | 2024 | 364870 | 0.320 |
Why?
|
| Clinical Trials as Topic | 4 | 2021 | 8051 | 0.320 |
Why?
|
| Awareness | 3 | 2018 | 653 | 0.320 |
Why?
|
| Female | 85 | 2024 | 397050 | 0.310 |
Why?
|
| Mental Recall | 5 | 2019 | 1226 | 0.310 |
Why?
|
| Humans | 104 | 2024 | 768298 | 0.300 |
Why?
|
| Psychiatric Status Rating Scales | 11 | 2017 | 6034 | 0.290 |
Why?
|
| Neocortex | 2 | 2024 | 417 | 0.290 |
Why?
|
| Parietal Lobe | 3 | 2024 | 866 | 0.280 |
Why?
|
| Loneliness | 2 | 2022 | 211 | 0.280 |
Why?
|
| Neurodegenerative Diseases | 1 | 2015 | 1094 | 0.260 |
Why?
|
| Cerebral Cortex | 6 | 2017 | 5830 | 0.240 |
Why?
|
| Linear Models | 8 | 2021 | 5878 | 0.230 |
Why?
|
| Frontal Lobe | 2 | 2024 | 1428 | 0.230 |
Why?
|
| Amyloidosis | 3 | 2018 | 879 | 0.230 |
Why?
|
| Magnetic Resonance Imaging | 22 | 2024 | 36849 | 0.220 |
Why?
|
| Presenilin-1 | 4 | 2020 | 665 | 0.200 |
Why?
|
| Learning Curve | 1 | 2023 | 225 | 0.190 |
Why?
|
| Radiopharmaceuticals | 6 | 2020 | 2734 | 0.190 |
Why?
|
| Cues | 3 | 2017 | 884 | 0.190 |
Why?
|
| Educational Status | 2 | 2020 | 2518 | 0.180 |
Why?
|
| Middle Aged | 35 | 2024 | 223463 | 0.180 |
Why?
|
| Names | 3 | 2015 | 54 | 0.180 |
Why?
|
| Psychometrics | 4 | 2023 | 3069 | 0.180 |
Why?
|
| Face | 4 | 2015 | 1031 | 0.170 |
Why?
|
| Agnosia | 2 | 2018 | 66 | 0.170 |
Why?
|
| Depression | 5 | 2024 | 8241 | 0.170 |
Why?
|
| Parahippocampal Gyrus | 1 | 2020 | 118 | 0.170 |
Why?
|
| Rehabilitation | 1 | 2020 | 131 | 0.170 |
Why?
|
| Independent Living | 2 | 2021 | 580 | 0.170 |
Why?
|
| Mental Competency | 1 | 2021 | 179 | 0.160 |
Why?
|
| Advisory Committees | 2 | 2021 | 797 | 0.160 |
Why?
|
| Spouses | 1 | 2021 | 286 | 0.150 |
Why?
|
| Phenanthrolines | 1 | 2017 | 49 | 0.150 |
Why?
|
| Personality | 1 | 2022 | 560 | 0.150 |
Why?
|
| Psychomotor Performance | 4 | 2019 | 1895 | 0.140 |
Why?
|
| Early Diagnosis | 1 | 2021 | 1195 | 0.130 |
Why?
|
| Verbal Learning | 3 | 2014 | 465 | 0.130 |
Why?
|
| Semantics | 2 | 2019 | 618 | 0.130 |
Why?
|
| Nootropic Agents | 1 | 2017 | 159 | 0.130 |
Why?
|
| Atrophy | 4 | 2024 | 1648 | 0.130 |
Why?
|
| Translations | 1 | 2015 | 84 | 0.120 |
Why?
|
| Neural Pathways | 2 | 2018 | 3121 | 0.120 |
Why?
|
| Telephone | 1 | 2019 | 630 | 0.120 |
Why?
|
| Colombia | 3 | 2021 | 287 | 0.120 |
Why?
|
| Cerebrovascular Circulation | 1 | 2024 | 2736 | 0.110 |
Why?
|
| Biomedical Research | 2 | 2021 | 3464 | 0.110 |
Why?
|
| Heterozygote | 2 | 2021 | 2792 | 0.100 |
Why?
|
| Olfaction Disorders | 1 | 2015 | 226 | 0.100 |
Why?
|
| Cohort Studies | 8 | 2024 | 41791 | 0.100 |
Why?
|
| Corpus Striatum | 1 | 2018 | 1236 | 0.100 |
Why?
|
| Mental Status Schedule | 3 | 2017 | 315 | 0.100 |
Why?
|
| Perception | 2 | 2015 | 1206 | 0.090 |
Why?
|
| Amyloidogenic Proteins | 2 | 2023 | 154 | 0.090 |
Why?
|
| Latin America | 2 | 2020 | 416 | 0.080 |
Why?
|
| Boston | 2 | 2023 | 9371 | 0.080 |
Why?
|
| European Union | 2 | 2021 | 157 | 0.070 |
Why?
|
| Mood Disorders | 1 | 2015 | 1129 | 0.070 |
Why?
|
| Alleles | 1 | 2019 | 6892 | 0.070 |
Why?
|
| Australia | 2 | 2022 | 1265 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2021 | 24316 | 0.070 |
Why?
|
| Educational Measurement | 1 | 2014 | 1256 | 0.070 |
Why?
|
| Fluorodeoxyglucose F18 | 4 | 2017 | 2056 | 0.070 |
Why?
|
| Reproducibility of Results | 4 | 2023 | 20224 | 0.060 |
Why?
|
| Registries | 1 | 2022 | 8378 | 0.060 |
Why?
|
| Motor Activity | 1 | 2015 | 2720 | 0.060 |
Why?
|
| Asymptomatic Diseases | 2 | 2019 | 590 | 0.060 |
Why?
|
| Sex Factors | 4 | 2021 | 10656 | 0.060 |
Why?
|
| Age Factors | 2 | 2017 | 18472 | 0.060 |
Why?
|
| Cognitive Reserve | 1 | 2024 | 92 | 0.060 |
Why?
|
| Life Style | 1 | 2015 | 3930 | 0.050 |
Why?
|
| Executive Function | 3 | 2018 | 1405 | 0.050 |
Why?
|
| Anxiety | 1 | 2018 | 4675 | 0.050 |
Why?
|
| Factor Analysis, Statistical | 2 | 2018 | 1004 | 0.050 |
Why?
|
| Gyrus Cinguli | 2 | 2018 | 1137 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 15455 | 0.050 |
Why?
|
| Apolipoproteins E | 2 | 2017 | 1459 | 0.040 |
Why?
|
| Quality of Life | 1 | 2022 | 13499 | 0.040 |
Why?
|
| Severity of Illness Index | 4 | 2021 | 15939 | 0.040 |
Why?
|
| Statistics as Topic | 2 | 2016 | 2363 | 0.040 |
Why?
|
| Financial Management | 1 | 2021 | 161 | 0.040 |
Why?
|
| Risk | 3 | 2016 | 9635 | 0.040 |
Why?
|
| Occipital Lobe | 1 | 2020 | 376 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2016 | 13050 | 0.040 |
Why?
|
| Video Games | 1 | 2020 | 202 | 0.040 |
Why?
|
| Geriatric Assessment | 2 | 2016 | 1422 | 0.040 |
Why?
|
| Reaction Time | 1 | 2023 | 2103 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 18047 | 0.030 |
Why?
|
| Mutation | 2 | 2019 | 30230 | 0.030 |
Why?
|
| Risk Factors | 3 | 2018 | 74954 | 0.030 |
Why?
|
| Contrast Media | 2 | 2019 | 5337 | 0.030 |
Why?
|
| Logistic Models | 3 | 2016 | 13323 | 0.030 |
Why?
|
| ROC Curve | 2 | 2014 | 3622 | 0.030 |
Why?
|
| Proportional Hazards Models | 3 | 2015 | 12557 | 0.030 |
Why?
|
| Massachusetts | 2 | 2021 | 8902 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2023 | 2353 | 0.030 |
Why?
|
| Limbic System | 1 | 2017 | 423 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2019 | 8730 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 15652 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2015 | 6541 | 0.030 |
Why?
|
| Spain | 1 | 2015 | 492 | 0.030 |
Why?
|
| Walking | 1 | 2020 | 1201 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2015 | 9063 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2017 | 4076 | 0.030 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2012 | 139 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2023 | 5311 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2023 | 54921 | 0.030 |
Why?
|
| Rest | 1 | 2017 | 951 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2015 | 948 | 0.020 |
Why?
|
| Nerve Net | 1 | 2024 | 2362 | 0.020 |
Why?
|
| Nerve Degeneration | 1 | 2015 | 749 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 39405 | 0.020 |
Why?
|
| Parents | 1 | 2024 | 3596 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2015 | 1727 | 0.020 |
Why?
|
| Molecular Imaging | 1 | 2017 | 827 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2021 | 2661 | 0.020 |
Why?
|
| Acoustic Stimulation | 1 | 2014 | 1253 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2020 | 2661 | 0.020 |
Why?
|
| Adult | 6 | 2020 | 223622 | 0.020 |
Why?
|
| Prognosis | 3 | 2015 | 30020 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 14736 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2019 | 16027 | 0.020 |
Why?
|
| United States | 3 | 2024 | 73144 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2015 | 2004 | 0.020 |
Why?
|
| Young Adult | 3 | 2020 | 60048 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2017 | 1959 | 0.020 |
Why?
|
| Age of Onset | 1 | 2014 | 3345 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2014 | 1539 | 0.020 |
Why?
|
| Brain Concussion | 1 | 2018 | 1433 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2015 | 1137 | 0.020 |
Why?
|
| Language | 1 | 2015 | 1558 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2018 | 3411 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2015 | 2122 | 0.010 |
Why?
|
| Nurses | 1 | 2014 | 2494 | 0.010 |
Why?
|
| Learning | 1 | 2014 | 1760 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2021 | 4874 | 0.010 |
Why?
|
| Reference Values | 1 | 2011 | 4941 | 0.010 |
Why?
|
| Oxygen | 1 | 2015 | 4273 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2021 | 22292 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2015 | 10117 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2017 | 6740 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8750 | 0.010 |
Why?
|
| Genotype | 1 | 2014 | 13038 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 13019 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 20766 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 89182 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2014 | 81768 | 0.000 |
Why?
|
| Animals | 1 | 2015 | 169322 | 0.000 |
Why?
|
Concepts
(180)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(57)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_